| Home | E-Submission | Sitemap | Editorial Office |  
top_img
 Best Practice

Principles of transparency and best practice

Annals of Clinical Neurophysiology (ACN) follows the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; http://doaj.org/bestpractice)

Table of Contents

1. Website
2. Name of the journal
3. Peer Review Process
4. Ownership and Management
5. Governing Body
6. Editorial Team and Contact Information
7. Copyright and Licensing
8. Author Fees
9. Process For Identifying And Dealing With Allegations Of Research Misconduct
10. Publication Ethics
11. Publishing Schedule
12. Access
13. Archiving
14. Revenue Sources
15. Advertising
16. Direct Marketing

1. Website

i. The URL of the official journal website is https://www.e-acn.org/. ii. Aims and scope statement (https://www.e-acn.org/about/index.php) iii. Readership (https://www.e-acn.org/about/index.php) iv. Authorship criteria (https://www.e-acn.org/authors/authors.php) v. pISSN: 2508-691X, eISSN: 2508-6960

2. Name of The Journal

The official journal name is Annals of Clinical Neurophysiology. The abbreviated name is Ann Clin Neurophysiol.

3. Peer review process (https://www.e-acn.org/authors/authors.php)

ACN adopts double blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. All submitted manuscripts will be initially evaluated by more than two experts in accordance with the review and revision guidelines of The Korean Society of Clinical Neurophysiology. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 4 weeks of the receipt of a manuscript, and the reviewers’ comments will be sent to the corresponding authors.

4. Ownership And Management

i. Ownership: The Korean Society of Clinical Neurophysiology (http://www.kscn.or.kr/).
ii. Management team (https://www.e-acn.org/about/editorial.php)

5/6. Governing Body/Editorial Team And Contact Information

The governing body is the Editorial Board of the journal (https://www.e-acn.org/about/editorial.php).

7. Copyright And Licensing

i. Copyright policy (https://www.e-acn.org/authors/authors.php)
All published papers become the permanent property of The Korean Society of Clinical Neurophysiology, and must not be published elsewhere without written permission. A copyright transfer form should be submitted to the Editorial Office through the electronic submission system at http://submit.e-acn.org upon acceptance.

ii. Licensing Information (https://www.e-acn.org/authors/access.php)
This is an open-access journal distributed under the terms of the Creative Commons Attribution Noncommercial license (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, and it is used only for noncommercial purposes.

8. Author Fees

(https://www.e-acn.org/authors/no_charge.php)

The authors do not pay any page charges or article processing charges.

9. Process For Identifying And Dealing With Allegations Of Research Misconduct

(https://www.e-acn.org/authors/guide.php)

When the journal faces suspected cases of research and publication misconduct–such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer’s appropriation of an author’s idea or data, and complaints against editors–the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flow-charts). Discussion and decisions on the suspected cases are carried out by the Editorial Board.

10. Publication Ethics

ACN follows the guideline on ‘Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr/)’, ‘Guideline on good publication (http://publicationethics.org/resources/guidelines)’, and Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations).
Our research and publication ethics are displayed on the ‘Publication Ethics’ tab of journal homepage.

11. Publishing Schedule

ACN is published twice yearly on April 30 and October 31.

12. Access

(https://www.e-acn.org/authors/access.php)

This is an open-access journal distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited, and it is used only for noncommercial purposes.

13. Archiving

The journal will be accessible without barriers from the Korea Citation Index (https://kci.go.kr) or the National Library of Korea (http://nl.go.kr) in the event that it is no longer published.

14. Revenue Sources

The journal receives financial support from the publisher (The Korean Society of Clinical Neurophysiology), the Korea government, and in-journal advertising.

15. Advertising

ACN accepts advertisements on the bases described below.

  • Eligibility of advertised products or services
    All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant to authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.
    - Advertising is separate from content. Advertisers and sponsors have no advance knowledge of the editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors do not influence any of the editorial decisions or advertising policies.
    - The journal reserves the right to decline or cancel any advertisement at any time.
    - Advertisements for pharmaceutical products must conform with all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea.

  • Orders
    Any individuals or organizations who are interested in advertising their products or services in the print copies of the journal or on its website are encouraged to contact the Editorial Office. The acceptance of advertisement will be discussed by the Editorial Board and will ultimately be approved by the publisher.

  • Advertisement fee
    The cost of an advertisement will follow the code of fair competition policy.

  • Disclaimer
    Liability: Neither the publisher nor the editors will be legally liable for advertisements published in the journal. In addition, they do not guarantee the accuracy, completeness, or usefulness of the information provided.
    Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
    Disclaimer: Neither the publisher nor the editors will be legally liable for any of the content of advertisements.

16. Direct Marketing

The journal is disseminated via the journal website. Invitations to submit a manuscript are usually directed at presenters at conferences, seminars, and workshops if the topics of their presentations are related to the aims and scope of the journal.

Editorial Office
Department of Neurology, Gyeongsang National University Changwon Hospital,
11, Samjeongja-ro, Seongsan-gu, Changwon-si, Gyeongsangnam-do, Republic of Korea
TEL : +82-10-3396-7312    FAX : +82-82-55-214-2638   E-mail: acn.journal@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Society of Clinical Neurophysiology.           Developed in M2PI